Holen Sie sich die Stockscreener-App
33.24
1.00%
0.33
Handel nachbörslich:
32.61
-0.63
-1.90%
Schlusskurs vom Vortag:
$32.91
Offen:
$32.36
24-Stunden-Volumen:
370.52K
Relative Volume:
0.78
Marktkapitalisierung:
$1.46B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.23%
1M Leistung:
+22.61%
6M Leistung:
+206.36%
1J Leistung:
+0.00%
1-Tages-Spanne:
$32.32
$33.74
1-Wochen-Bereich:
$30.32
$34.29
52-Wochen-Spanne:
$6.71
$34.29
Maze Therapeutics Inc Stock (MAZE) Company Profile
Firmenname
Maze Therapeutics Inc
Sektor
Branche
Telefon
(650) 850-5070
Adresse
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Vergleichen Sie MAZE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
33.24 | 1.58B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-02 | Eingeleitet | BTIG Research | Buy |
| 2025-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-08 | Eingeleitet | Wedbush | Outperform |
Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten
Can you recover from losses in Maze Therapeutics Inc.Entry Point & Scalable Portfolio Growth Ideas - newser.com
Is Maze Therapeutics Inc. stock attractive for long term wealth building2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Maze Therapeutics Inc. stock momentum explained2025 Trading Recap & Intraday High Probability Alerts - newser.com
Heatmap analysis for Maze Therapeutics Inc. and competitors2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Is Maze Therapeutics Inc. stock recession proofEarnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com
What is the fair value of Maze Therapeutics Inc. stock now2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Can Maze Therapeutics Inc. stock beat market expectations this quarterWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Is Maze Therapeutics Inc. stock oversold or undervaluedMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Regression analysis insights on Maze Therapeutics Inc. performanceMarket Trend Review & Reliable Entry Point Alerts - newser.com
Will Maze Therapeutics Inc. outperform the marketAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
How institutional buying supports Maze Therapeutics Inc. stockIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com
Does Maze Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Applying chart zones and confluence areas to Maze Therapeutics Inc.July 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Pattern recognition hints at Maze Therapeutics Inc. upsideTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Analyzing Maze Therapeutics Inc. with multi timeframe chartsJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-11-01 11:35:52 - newser.com
Published on: 2025-11-01 02:20:20 - newser.com
Maze Therapeutics (NASDAQ:MAZE) Trading 9.6% HigherShould You Buy? - MarketBeat
Top chart patterns to watch in Maze Therapeutics Inc.Analyst Downgrade & Safe Capital Growth Plans - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Published on: 2025-10-31 01:35:39 - newser.com
Why Maze Therapeutics Inc. is moving todayWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Published on: 2025-10-30 05:09:48 - newser.com
Maze Therapeutics (NASDAQ:MAZE) Hits New 12-Month HighShould You Buy? - MarketBeat
Finanzdaten der Maze Therapeutics Inc-Aktie (MAZE)
Es liegen keine Finanzdaten für Maze Therapeutics Inc (MAZE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):